Treatment Options in Advanced mCSPC

Insights from 2024 ASCO® GU Annual Meeting
G

ASCO® GU 2024 Insights: "PROMPT-2 Trial - PSA Response Among Patients With mCSPC Initiated on Apalutamide or Abiraterone Acetate in Real-World Urology Practices"

By Insights from 2024 ASCO® GU Annual Meeting FEATURING Gordon Brown
By Insights from 2024 ASCO® GU Annual Meeting FEATURING Gordon Brown
211 views
February 9, 2024
0 Comments
Login to view comments. Click here to Login
18:59

Management of Toxicities Associated With ARSi+ADT Therapy in mCSPC

Jochen Walz

174 views
12:39

ASCO® GU 2024 Insights: "Prognostic Value of FDG, PSMA, and DOTATATE…

Insights from 2024 ASCO® GU Annual Meeting

F. Pouliot

95 views
17:26

Local Treatment of the Prostate in Synchronous mHSPC

PROSCA & BLADDR 2023

A. Bossi

162 views
15:59

PSA Attainment & Reduction in Frontline mHSPC

Moffitt Cancer Center

J. Chadha

142 views
21:17

Time to Castrate Resistance in mCSPC Using Standard of Care Intensif…

Manish Kohli

545 views
03:49

ESMO 2023 Insights: "Effect of Rapid Ultra-Low Prostate-Specific Ant…

Insights from 2023 ESMO Annual Meeting

A. Merseburger

459 views
18:42

Theragnostics in Metastatic Prostate Cancer: Diagnosis and Treatment

International Urology Cancer Summit - IUCS

G. Gnanasegaran

249 views
23:23

New Imaging Technology in Prostate Cancer

Fox Chase Cancer Center

J. Yu

427 views